Patents Assigned to GJN INTERNATIONAL LLC
  • Publication number: 20230380761
    Abstract: The embodiments disclose a method including: monitoring vital signs of an opioid patient, providing chemical identifying and concentration detection of a drug the opioid patient is preparing to inject, analyzing the opioid patient's vital signs to determine an overdose condition regardless of the patient consciousness state, tracking the opioid patient's GPS location, transmitting automatically an overdose emergency alert; sending the automatic opioid overdose emergency alert to the closest first responders, and providing the opioid patient's ID, GPS location, vital signs, potential drug overdosed, and known drug use in the automatic opioid overdose emergency alert to the closest first responders.
    Type: Application
    Filed: August 11, 2023
    Publication date: November 30, 2023
    Applicant: GJN INTERNATIONAL LLC
    Inventors: Renaya Furtick Wheelan, Scott Shanks
  • Patent number: 11723593
    Abstract: The embodiments disclose a method including: monitoring vital signs of an opioid patient, providing chemical identifying and concentration detection of a drug the opioid patient is preparing to inject, analyzing the opioid patient's vital signs to determine an overdose condition regardless of the patient consciousness state, tracking the opioid patient's GPS location, transmitting automatically an overdose emergency alert; sending the automatic opioid overdose emergency alert to the closest first responders, and providing the opioid patient's ID, GPS location, vital signs, potential drug overdosed, and known drug use in the automatic opioid overdose emergency alert to the closest first responders.
    Type: Grant
    Filed: May 29, 2022
    Date of Patent: August 15, 2023
    Assignee: GJN INTERNATIONAL LLC
    Inventor: Renaya Furtick Wheelan